Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!

Allison B. Hall, Emmanouil S. Brilakis

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations


Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein graft Angioplasty and Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? Trial) definitely show no difference between the two stent types, suggesting that bare metal stents should be preferred given lower cost. Since SVG stenting remains associated with high failure rates, alternative treatment strategies, such as intervention of the corresponding native coronary artery lesions, may represent the future direction of the field.

Original languageEnglish (US)
Pages (from-to)E193-E194
JournalCatheterization and Cardiovascular Interventions
Issue number3
StatePublished - Feb 15 2019
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!'. Together they form a unique fingerprint.

Cite this